This week, Theradaptive, a leading biotechnology company specializing in therapeutic delivery platforms, presents a new abstract demonstrating the efficacy and safety of the company's novel AMP2...
SynerFuse, Inc., a Minneapolis-basedMinnesota company, is pleased to announce the first implantation in the company's proof-of-concept study. The study will evaluate the safety and...
